PUBLISHER: The Business Research Company | PRODUCT CODE: 1945386
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945386
Insulin patch pumps, compact computerized devices with pre-programmed insulin dosage delivery, offer diabetic patients a convenient means of managing their blood sugar levels. Typically attached to a strap beneath clothing, in a pocket, on a waist belt, or affixed with an adhesive patch on the patient's stomach or arm, these devices facilitate discreet and accessible insulin administration.
The primary categories of insulin patch pumps include traditional insulin pumps, smart insulin pumps, and disposable insulin pumps. Traditional insulin pumps are small devices that deliver insulin through a plastic tube, providing a continuous supply throughout the day and night. Additionally, before meals, they can administer insulin more rapidly, employing the basal and bolus delivery modes. These pumps are available in two types: tethered pumps and patch pumps, catering to patients with both type 1 and type 2 diabetes. Widely utilized in hospitals, clinics, laboratories, and other medical settings, these insulin patch pumps play a pivotal role in diabetes management.
Tariffs are impacting the insulin patch pumps market by increasing costs of imported sensors, micro-pumps, electronic controllers, batteries, and medical-grade plastics. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces higher production costs for exports. These tariffs are raising device prices and slowing adoption rates. However, they are also supporting local manufacturing, regional electronics sourcing, and innovation in cost-efficient wearable insulin delivery solutions.
The insulin patch pumps market research report is one of a series of new reports from The Business Research Company that provides insulin patch pumps market statistics, including insulin patch pumps industry global market size, regional shares, competitors with a insulin patch pumps market share, detailed insulin patch pumps market segments, market trends and opportunities, and any further data you may need to thrive in the insulin patch pumps industry. This insulin patch pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The insulin patch pumps market size has grown rapidly in recent years. It will grow from $1.56 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing prevalence of diabetes worldwide, rising demand for intensive insulin therapy, expansion of insulin pump adoption, improvements in wearable medical device technology, growing patient awareness of advanced diabetes management.
The insulin patch pumps market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing adoption of closed-loop insulin delivery systems, rising investments in digital diabetes care, expansion of personalized insulin therapy solutions, increasing demand for remote glucose monitoring, advancements in miniaturized pump technologies. Major trends in the forecast period include increasing adoption of tubeless patch pump systems, rising demand for connected and smart insulin pumps, growing integration of continuous glucose monitoring, expansion of automated insulin delivery technologies, enhanced focus on discreet and wearable designs.
The increasing prevalence of diabetes worldwide is expected to drive the growth of the insulin patch pumps market during the forecast period. Diabetes is a major global health concern, often influenced by lifestyle and dietary habits. Insulin patch pumps facilitate the convenient delivery of insulin directly into the body, and many people with diabetes find them more practical than traditional insulin injections. The rising number of diabetes cases is therefore creating a growing demand for insulin patch pumps. For example, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%. Additionally, the proportion of patients achieving target HbA1c levels reached 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Consequently, the global increase in diabetes prevalence is expected to propel the insulin patch pumps market.
Companies in the insulin patch pumps market are focusing on product innovation, such as advanced infusion sets, to provide reliable and convenient insulin delivery solutions. Infusion sets for insulin pumps are designed for continuous subcutaneous insulin infusion, typically worn for up to seven days. For instance, in September 2024, Embecta, a U.S.-based diabetes care company, received FDA 510(k) clearance for its first insulin patch pump, featuring a 300-unit insulin reservoir and designed for up to three days of wear. This launch represents a significant advancement in insulin delivery, offering patients a flexible and convenient option while reducing device burden.
In January 2023, Tandem Diabetes Care Inc., a US-based medical device manufacturer, acquired AMF Medical SA for an undisclosed amount. This acquisition allows Tandem Diabetes Care to expand its diabetes care portfolio and extend the benefits of advanced insulin pump therapy to more patients. AMF Medical SA is a Switzerland-based MedTech company specializing in the development of insulin patch pumps.
Major companies operating in the insulin patch pumps market are Insulet Corporation, Medtronic PLC, Tandem Diabetes Care Inc., Ypsomed Holding AG, AMF Medical SA, Cequr SA, Debiotech SA, Bigfoot Biomedical Inc., Valeritas Inc., Cellnovo Group SA, Medella Health Ltd., ViCentra B.V., SFC Fluidics Inc., Pancreum Inc., Beta Bionics Inc., Embecta Corp., SOOIL Development Co. Ltd., EOFLOW Co. Ltd., 3S Corporation, Apex Medical Devices
North America was the largest region in the insulin patch pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin patch pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the insulin patch pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The insulin patch pumps market consist of sales of insulin reservoir, pumping, mechanism and cannula. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Insulin Patch Pumps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses insulin patch pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for insulin patch pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insulin patch pumps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.